Omada Health director receives 649 RSUs as fee in stock

Omada Health, Inc. director Julie D. Klapstein reported receiving an equity grant of 649 shares of Common Stock in the form of restricted stock units.

Rhea-AI Filing Summary

Omada Health, Inc. director Julie D. Klapstein reported receiving an equity grant of 649 shares of Common Stock in the form of restricted stock units. These RSUs were awarded at no cash cost per share under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees.

After this grant, Klapstein directly holds a total of 21,965 shares of Common Stock. The RSUs each represent the right to receive one share of Common Stock, with settlement occurring on a date selected by the director under the program or as otherwise provided by the plan. This is a routine, compensation-related acquisition rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 649 shares

Grant/Award 1 txn

Insider Klapstein Julie D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	649	$0.00	$0.00

Holdings After Transaction: Common Stock — 21,965 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

Key Figures

RSUs granted: 649 shares Grant price per share: $0.00 per share Total holdings after grant: 21,965 shares +1 more

4 metrics

RSUs granted 649 shares Restricted stock units granted in lieu of retainer fees

Grant price per share $0.00 per share Stated transaction price for RSU award

Total holdings after grant 21,965 shares Common Stock directly held by Julie D. Klapstein after transaction

Transaction code A Grant, award, or other acquisition of non-derivative securities

Key Terms

restricted stock units ("RSUs"), Non-Employee Director Compensation Program, retainer fees, restricted stock units

4 terms

restricted stock units ("RSUs") financial

"Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Non-Employee Director Compensation Program financial

"that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees"

retainer fees financial

"RSUs that were granted pursuant to the Issuer's Non-Employee Director Compensation Program in lieu of retainer fees"

restricted stock units financial

"Each RSU represents the right to receive one (1) share of Common Stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Omada Health (OMDA) disclose for Julie D. Klapstein?

Omada Health disclosed that director Julie D. Klapstein received 649 restricted stock units as equity compensation. The award was granted in lieu of cash retainer fees under the Non-Employee Director Compensation Program and is classified as a grant or award acquisition, not an open-market stock purchase.

How many Omada Health (OMDA) shares does Julie D. Klapstein hold after this Form 4?

Following the reported grant, Julie D. Klapstein directly holds 21,965 shares of Omada Health Common Stock. This total includes the 649 restricted stock units awarded under the Non-Employee Director Compensation Program, each representing the right to receive one share upon settlement as specified by the plan.

Was the Omada Health (OMDA) Form 4 transaction a market buy or a compensation grant?

The Form 4 transaction for Omada Health was a compensation-related grant, not a market purchase. Julie D. Klapstein received 649 restricted stock units at a stated price of $0.00 per share in lieu of cash director retainer fees under the company’s Non-Employee Director Compensation Program.

What are the terms of the RSUs granted to Omada Health (OMDA) director Julie D. Klapstein?

Each restricted stock unit granted to Julie D. Klapstein represents the right to receive one share of Omada Health Common Stock. Settlement will occur either on a date she selects pursuant to the Non-Employee Director Compensation Program or as otherwise provided by that program’s terms.

Why did Omada Health (OMDA) grant RSUs instead of cash to Julie D. Klapstein?

The filing states that the 649 restricted stock units were granted in lieu of retainer fees under Omada Health’s Non-Employee Director Compensation Program. This program allows non-employee directors to receive equity awards rather than cash, aligning a portion of board compensation with company stock performance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/07/2026 - 07:26 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Klapstein Julie D

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD., SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/05/2026		A		649(1)	A	$0	21,965	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

	/s/ Nathan Salha, as Attorney-in-Fact for Julie D. Klapstein	07/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)